Lixiana – Edoxaban uses, dose and side effects

}

15 mg, 30 mg, and 60 mg film-coated tablets
edoxaban

What Lixiana is and what it is used for

Lixiana contains the active substance edoxaban and belongs to a group of medicines called anticoagulants (blood thinners). This medicine helps to prevent the formation of blood clots by blocking the activity of factor Xa, which is an important component in the clotting of the blood.

Lixiana is used in adults to:

  • prevent blood clots in the brain ( stroke ) and in other blood vessels in the body if you have a form of irregular heart rhythm called non-valvular atrial fibrillation and another at least one risk factor, e.g. heart failure , previous stroke ( stroke ) or high blood pressure
  • treat blood clots in the veins in the legs (deep vein thrombosis ) and in the blood vessels in the lungs ( pulmonary embolism ) and to prevent blood clots from recurring in the blood vessels in the legs and / or lungs.

What you need to know before you take Lixiana

Do not take Lixiana

  • if you are allergic to edoxaban or any of the other ingredients of this medicine (listed in section 6)
  • if you have an ongoing bleeding
  • if you have a disease or condition that increases the risk of severe bleeding (eg stomach ulcers , injury or bleeding in the brain, or recent brain or eye surgery )
  • if you are taking other medicines to prevent the blood from clotting (eg warfarin , dabigatran, rivaroxaban, apixaban or heparin ), except when changing anticoagulant therapy or if you have a venous or arterial catheter flushed with heparin to keep the catheter is open
  • if you have a liver disease that leads to an increased risk of bleeding
  • if you have uncontrolled high blood pressure
  • if you are pregnant or breastfeeding.

Warnings and cautions

Talk to your doctor or pharmacist before taking Lixiana:

  • if you have an increased risk of bleeding, which may be the case if you have any of the following diseases:
    • end-stage renal disease or if you receive dialysis
    • severe liver disease
    • bleeding disorders
    • problems with the blood vessels in the fundus ( retinopathy )
    • if you have recently had a brain haemorrhage ( intracranial or intracerebral haemorrhage)
    • problems with the blood vessels in the brain or spine
  • if you have a mechanical heart valve.

Lixiana 15 mg should only be used when switching from Lixiana 30 mg to a vitamin K antagonist (eg warfarin ) (see section 3, How to take Lixiana).

Take special care with Lixiana

  • If you know you have a condition called antiphospholipid syndrome (a disorder of the immune system that increases the risk of getting blood clots), tell your doctor, who will decide if treatment may need to be changed.

If you need surgery

  • it is very important to take Lixiana before and after the operation at exactly the times that the doctor says. If possible, stop taking Lixiana at least 24 hours before surgery. Your doctor will decide when to start taking Lixiana again.In emergency situations, your doctor will decide what action to take when taking Lixiana.

Children and young people

Lixiana is not recommended for children or adolescents under 18 years of age. There is no information on use in children and adolescents.

Other medicines and Lixiana

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

If you take any of the following:

  • certain medicines for fungal infections (eg ketoconazole )
  • drugs for the treatment of abnormal heart rhythms (eg dronedarone, quinidine , verapamil)
  • other drugs that reduce the ability of the blood to clot (eg heparin , clopidogrel or vitamin K antagonists such as warfarin , acenocoumarol, fenprocumon or dabigatran, rivaroxaban, apixaban)
  • antibiotics (eg erythromycin)
  • drugs that prevent organ rejection after transplantation (eg cyclosporine)
  • anti-inflammatory and analgesic drugs (eg naproxen or acetylsalicylic acid )
  • antidepressant drugs, so-called selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors.


If any of the above applies to you, tell your doctor before taking Lixiana, as these medicines may increase the effects of Lixiana and the risk of unwanted bleeding. Your doctor will then decide if you should be treated with Lixiana and if you need to be monitored.

If you take any of the following:

  • certain medicines to treat epilepsy (eg phenytoin , carbamazepine, phenobarbital)
  • St. John’s wort , an herbal medicine used to treat anxiety and mild depression
  • rifampicin, an antibiotic .

If any of the above applies to you, tell your doctor before taking Lixiana, as the effect of Lixiana may be reduced. Your doctor will then decide if you should be treated with Lixiana and if you need to be monitored.

Pregnancy and breastfeeding

Do not take Lixiana if you are pregnant or breastfeeding. If you are at risk of becoming pregnant, use a reliable contraceptive while you are taking Lixiana. If you become pregnant while taking Lixiana, tell your doctor immediately, who will decide how to treat you.

Driving and using machines

Lixiana has no or negligible effect on the ability to drive and use machines.

How to take Lixiana

Always take this medicine exactly as your doctor or pharmacist has told you. Ask your doctor or pharmacist if you are unsure.

How much to take

The recommended dose is one 60 mg tablet once a day.

  • if you have impaired kidney function , your doctor may reduce your dose to one 30 mg tablet once a day.
  • If your body weight is 60 kg or less , the recommended dose is one 30 mg tablet once a day.
  • if your doctor has prescribed medicines called P-gp inhibitors: ciclosporin, dronedarone, erythromycin or ketoconazole , the recommended dose is one 30 mg tablet once a day.

How to take the tablet

Swallow the tablet, preferably with water.

Lixiana can be taken with or without food.

If it is difficult for you to swallow the tablet whole, talk to your doctor about other ways to take Lixiana. The tablet can be crushed and mixed with water or apple puree immediately before taking it. If needed, your doctor may also give you the crushed Lixiana tablet by gavage.

Your doctor may change your blood-thinning treatment as follows:

Switching from vitamin K antagonists (eg warfarin ) to Lixiana

Stop taking the vitamin K antagonist (eg warfarin ). Your doctor will need to take blood samples and inform you when to start taking Lixiana.

Switching from oral (oral) non-vitamin D antagonists (dabigatran, rivaroxaban or apixaban) to Lixiana

Stop taking the previous medicines (eg dabigatran, rivaroxaban, or apixaban) and start taking Lixiana at the time of your next scheduled dose.

Change from parenteral (injected) blood thinner (eg heparin ) to Lixiana

Stop taking the blood thinner (eg heparin ) and start taking Lixiana at the time of the next scheduled dose of the blood thinner.

Switching from Lixiana to Vitamin K Antagonists (eg warfarin )

If you are currently taking 60 mg Lixiana:

Your doctor will tell you to reduce the dose of Lixiana to a 30 mg tablet once a day and to take it with a vitamin K antagonist (eg warfarin ). Your doctor will need to take blood samples and inform you when to stop taking Lixiana.

If you are currently taking 30 mg (reduced dose ) Lixiana:

Your doctor will tell you to reduce the dose of one of Lixiana to a 15 mg tablet once a day and to take it with a vitamin K antagonist (eg warfarin ). Your doctor will need to take blood samples and inform you when to stop taking Lixiana.

Switching from Lixiana to blood thinners other than vitamin K antagonists (dabigatran, rivaroxaban, or apixaban)

Stop taking Lixiana and start with the blood thinner that is not a vitamin K antagonist (eg dabigatran, rivaroxaban, or apixaban) at the time of the next scheduled dose of Lixiana.

Switching from Lixiana to parenteral (injected) blood thinners (eg heparin )

Stop taking Lixiana and start with the parenteral (injected) blood thinner (eg heparin ) at the time of your next scheduled dose of Lixiana.

Patients undergoing electrical conversion:

If your irregular heartbeat needs to be restored to a normal rhythm, through a procedure called electrical conversion, you should take Lixiana at the times prescribed by your doctor to prevent blood clots in the brain and other blood vessels in the body.

If you take more Lixiana than you should

Tell your doctor immediately if you have taken too many Lixiana tablets.

If you take more Lixiana than recommended, the risk of bleeding may increase.

If you forget to take Lixiana

You should take the tablet immediately and then continue the next day with one tablet daily as usual. Do not take a double dose on the same day to make up for a forgotten dose.

If you stop taking Lixiana

Do not stop taking Lixiana without talking to a doctor first, as Lixiana treats and prevents serious conditions.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Like other similar medicines (medicines that reduce the risk of blood clots), Lixiana can cause life-threatening bleeding. In some cases, the bleeding may not be visible.

If you experience bleeding that does not stop on its own or if you experience signs of heavy bleeding (unusual weakness, fatigue, paleness, dizziness, headache, or unexplained swelling), you should contact a doctor immediately. Your doctor may decide that you should be monitored more closely or change your medicine.

The overall list of possible side effects:

Common (may affect up to 1 in 10 people):

  • magont
  • abnormal liver values ​​(shown in blood tests)
  • bleeding in the skin or under the skin
  • anemia (low red blood cell count )
  • nosebleeds
  • vaginal bleeding
  • rash
  • bleeding in the intestine
  • bleeding from the mouth and / or throat
  • blood in the urine
  • bleeding after an injury (puncture)
  • bleeding in the stomach
  • dizziness
  • nausea
  • headache
  • itching .

Uncommon (may affect up to 1 in 100 people):

  • bleeding in the eyes
  • bleeding from a surgical wound after surgery
  • bloody vomiting
  • bleeding in the brain
  • other types of bleeding
  • low platelet count (which can affect coagulation )
  • allergic reaction
  • hives.

Rare (may affect up to 1 in 1,000 people):

  • bleeding in the muscles
  • bleeding in joints
  • bleeding in the abdomen
  • bleeding in the heart
  • bleeding inside the skull
  • bleeding after a surgical procedure.
  • severe allergic reaction (allergic shock )
  • swelling in any part of the body due to allergic reaction .

How to store Lixiana

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and any blister or jar after EXP. The expiration date is the last day of the specified month.

No special storage instructions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Contents of the pack and other information

Content declaration

  • The active substance is edoxaban (as tosilate).Lixiana 15 mg film-coated tabletsEach tablet contains 15 mg of edoxaban (as tosilate).
    Lixiana 30 mg film-coated tabletsEach tablet contains 30 mg of edoxaban (as tosilate).
    Lixiana 60 mg film-coated tabletsEach tablet contains 60 mg of edoxaban (as tosilate).
  • Other ingredients are:Lixiana 15 mg g film-coated tabletsTablet core: mannitol (E421), pregelatinized starch , crospovidone (E1202), hydroxypropylcellulose (E463), magnesium stearate (E470b).Film coating; hypromellose (E464), macrogol (8000), titanium dioxide (E171), talc (E553b), carnauba wax, red iron oxide (E172), yellow iron oxide (E172).
    Lixiana 30 mg film-coated tabletsTablet core: mannitol (E421), pregelatinized starch , crospovidone (E1202), hydroxypropylcellulose (E463), magnesium stearate (E470b).Film coating: hypromellose (E464), macrogol (8000), titanium dioxide (E171), talc (E553b), carnauba wax, red iron oxide (E172).
    Lixiana 60 mg film-coated tabletsTablet core: mannitol (E421), pregelatinized starch , crospovidone (E1202), hydroxypropylcellulose (E463), magnesium stearate (E470b).Film coating: hypromellose (E464), macrogol (8000), titanium dioxide (E171), talc (E553b), carnauba wax, yellow iron oxide (E172).

What the medicine looks like and contents of the pack

Lixiana 15 mg film-coated tablets are orange, round (6.7 mm in diameter), and marked with “DSC L15” on one side.

They are supplied in blisters in cartons of 10 film-coated tablets or single-dose blisters in cartons of 10 x 1 film-coated tablets.

Lixiana 30 mg film-coated tablets are pink, round (8.5 mm in diameter), and marked with “DSC L30” on one side.

They are supplied in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets or single-dose blisters in cartons of 10 x 1, 50 x 1 or 100 x 1 film-coated tablets or in cans of 90 film-coated tablets.

Lixiana 60 mg film-coated tablets are yellow, round (10.5 mm in diameter), and marked with “DSC L60” on one side.

They are supplied in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets or single-dose blisters in cartons of 10 x 1, 50 x 1 or 100 x 1 film-coated tablets or in cans of 90 film-coated tablets.

Not all pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorisation Holder

Daiichi Sankyo Europe GmbH

Zielstattstrasse 48

81379 Munich

Germany

Manufacturer

Daiichi Sankyo Europe GmbH

Luitpoldstrasse 1

85276 Pfaffenhofen

Germany

Contact the representative of the marketing authorization holder to find out more about this medicine:

Belgium / Belgique / BelgienDaiichi Sankyo Belgium NV-SATel: + 32- (0) 2 227 18 80LithuaniaUAB “SERVIER PHARMA”Tel: +370 (5) 2 63 86 28
BulgariaDaiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0Luxembourg / LuxemburgDaiichi Sankyo Belgium NV-SATel: + 32- (0) 2 227 18 80
Czech RepublicOrganon Czech Republic sroTel: +420 233 010 300HungaryOrganon Hungary Kft.Tel .: +36 30 553 7713
DenmarkOrganon Denmark ApSTel: +45 4484 6800MaltaDaiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0
GermanyDaiichi Sankyo Deutschland GmbHTel. + 49- (0) 89 7808 0The NetherlandsDaiichi Sankyo Nederland BVTel: + 31- (0) 20 4 07 20 72
EestiServier Laboratories OÜTel: +372 664 5040NorwayOrganon Norway ASTel: +47 24 14 56 60
GreeceDaiichi Sankyo Europe GmbH:Ηλ: + 49- (0) 89 7808 0AustriaDaiichi Sankyo Austria GmbHTel: + 43- (0) 1 485 86 42 0
SpainDaiichi Sankyo España, SATel: +34 91539 99 11PolandDaiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0
FranceDaiichi Sankyo France SASTel: + 33- (0) 1 55 62 14 60PortugalDaiichi Sankyo Portugal, Unip. LDATel: +351 21 4232010
CroatiaDaiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0RomaniaDaiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0
IrelandDaiichi Sankyo Ireland LtdTel: + 353- (0) 1 489 3000SloveniaDaiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0
IcelandVistor hf.Phone: +354 535 7000Slovak RepublicOrganon Slovakia sroTel: +421 2 44 88 98 88
ItalyDaiichi Sankyo Italia SpATel: + 39-06 85 2551Finland / FinlandOrganon Finland OyPuh / Tel: +358 (0) 29 170 3520
.ΠροςDaiichi Sankyo Europe GmbH:Ηλ: + 49- (0) 89 7808 0SwedenOrganon Sweden ABTel: +46 8 502 597 00
LatviaSIA Servier LatviaTel: +371 67502039United Kingdom (Northern Ireland)Daiichi Sankyo Europe GmbHTel: + 49- (0) 89 7808 0

Leave a Reply